Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Halme

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancerP Maasilta, L R Holsti, M Halme, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytesM Halme, P Maasilta, H Repo, et al.
British Journal of Cancer|September 1, 1999
High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesotheliomaM Halme, A Knuuttila, T Vehmas, et al.
Transfusion Medicine (Oxford, England)|July 29, 2014
Successful liver and lung transplantation in patients with severe IgA deficiency, high anti-IgA concentration and a history of anaphylactic transfusion reactionS Bäckman, K Javela, A M Koivusalo, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytesM Halme, P Maasilta, H Repo, et al.
Anti-Cancer Drugs|November 1, 1996
A phase II trial of docetaxel in advanced non-small cell lung cancerA Saarinen, A Jekunen, M Halme, et al.
Respiratory Medicine|September 26, 2003
Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthmaE M Karjalainen, A Lindqvist, L A Laitinen, et al.
Biochemical and Biophysical Research Communications|July 15, 1994
Constrained analogues of the calcitonin gene-related peptideJ M Hakala, T Valo, S Vihavainen, et al.
Anti-Cancer Drugs|July 18, 2000
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility studyA Knuuttila, T Ollikainen, M Halme, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1999
Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alphaM Halme, M Hallman, T Ruotsalainen, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancerP Maasilta, L R Holsti, M Halme, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytesM Halme, P Maasilta, H Repo, et al.
British Journal of Cancer|September 1, 1999
High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesotheliomaM Halme, A Knuuttila, T Vehmas, et al.
Transfusion Medicine (Oxford, England)|July 29, 2014
Successful liver and lung transplantation in patients with severe IgA deficiency, high anti-IgA concentration and a history of anaphylactic transfusion reactionS Bäckman, K Javela, A M Koivusalo, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytesM Halme, P Maasilta, H Repo, et al.
Anti-Cancer Drugs|November 1, 1996
A phase II trial of docetaxel in advanced non-small cell lung cancerA Saarinen, A Jekunen, M Halme, et al.
Respiratory Medicine|September 26, 2003
Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthmaE M Karjalainen, A Lindqvist, L A Laitinen, et al.
Biochemical and Biophysical Research Communications|July 15, 1994
Constrained analogues of the calcitonin gene-related peptideJ M Hakala, T Valo, S Vihavainen, et al.
Anti-Cancer Drugs|July 18, 2000
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility studyA Knuuttila, T Ollikainen, M Halme, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 1999
Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alphaM Halme, M Hallman, T Ruotsalainen, et al.
Pageof 5